”Infections related to Antibiotic Resistent Bacteria (ARB) causes worldwide around 500,000 deaths yearly. This is an increasing threat and year 2050 it´s calculated that 10 million people will die in infections caused by ARB. Sepsis is defined as a life-threatening organ dysfunction due to a dysregulated host response to infection. It is a common disease with a high mortality rate. The cornerstone of treatment today is broad-spectrum antibiotics, but increasing resistance challenges the usage. A new technology, with a completely different approach, could be a valuable contribution in the future treatment”